[1] Tsujimoto T,Finger LR,Yunis J,et al.Cloning the chromosome breakpoint of neoplastic B-cells with the t(14;18) chromosome translocation.Science,1984,226:1097-1099. [2] Talal N.Concluding remarks:autogenes and oncogenes.Clin Immunol Immunopathol,1994,72:208-209. [3] 唐福林,董怡,陈培珍,等.系统性红斑狼疮和类风湿性关节炎病人血清中抗组蛋白抗体的测定及其临床意义.中华内科杂志,1990,29:221-223. [4] Tu Y,Xu F,Liu J,et al.Upregulated expression of bcl-2 in multiple myeloma cells induced by exposure to doxorubincin,etoposide,and hydrogen peroxide.Blood,1996,88:1805-1812. [5] Ohsako S,Hara M,Harigai M,et al.Expression and function of fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes.Clin Immunol Immunopathol,1994,73:109-114. [6] Aringer M,Wintersberger W,Steiner CW,et al.High levels of bcl-2 protein in circulating T lymphocytes,but not B lymphocytes,of patients with systemic lupus erythematosus.Arthritis Rheum,1994,37:1423-1430. [7] Graninger WB.Transcriptional overexpression of the protooncogene bcl-2 in patients with systemic lupus erythematosus.Wien Wlin Wochenschr,1992,104:205-207. [8] Strasser A,Harris AW,Cory SB.bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.Cell,1991,67:889-899. |